 |
市場調查報告書
商品編碼
2050877
慢性疼痛市場：按藥物類別、適應症、應用、分銷管道和地區分類Chronic Pain Market, By Drug Class, By Indication, By Application, By Distribution Channel, By Geography |
||||||
價格
簡介目錄
預計到2026年，慢性疼痛市場規模將達到830.2億美元，到2033年將達到1,368.4億美元。預計從2026年到2033年，該市場將以7.4%的複合年成長率成長。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2025 | 2026年市場規模： | 830.2億美元 |
| 歷史數據時期： | 2020-2024 | 預測期： | 2026-2033 |
| 2026年至2033年預測期間的複合年成長率： | 7.40% | 2033年市場規模預測： | 1368.4億美元 |
慢性疼痛是指持續超過三個月或超過常規治療療程的疼痛。多種疾病都可能導致慢性疼痛，包括關節炎、背痛、癌症、神經系統疾病和纖維肌痛。久坐的生活方式和慢性疾病盛行率的上升可能是全球慢性疼痛盛行率增加的原因之一。慢性疼痛會限制身體活動和日常生活，進而對生活品質產生負面影響。全球慢性疼痛市場涵蓋疼痛管理藥物、神經調節設備以及其他能夠緩解疼痛並改善患者預後的治療方法。易患這些疾病的老年人口的快速成長、醫療保健成本的上升、新產品的推出以及人們對治療方法日益成長的認知，都可能推動市場成長。
市場動態
慢性疾病和損傷的日益普遍是全球慢性疼痛發病率上升的主要原因之一。這包括骨關節炎和腰痛等肌肉骨骼疾病。老年人口的成長（老年人更容易患上這些疾病）可能會推動市場成長。此外，醫療保健支出的增加、新產品的創新以及支付昂貴治療方法的能力的提高也可能促進市場成長。然而，學名藥等替代藥物的存在、較低的用藥依從性以及某些治療方法的副作用，都可能對參與企業構成挑戰。此外，新產品核准的監管障礙也可能阻礙市場成長。新興市場為產業相關人員提供了巨大的機會。疼痛治療方法技術的進步有望為市場成長開闢新的途徑。
本研究的關鍵特徵
- 本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
- 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
- 本研究根據以下參數對全球慢性疼痛市場的主要參與者進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
- 透過利用本報告中的見解，企業行銷負責人和經營團隊可以就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
- 全球慢性疼痛市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
- 相關人員可以透過利用分析全球慢性疼痛市場中使用的各種策略矩陣，更輕鬆地做出決策。
目錄
第1章：研究目標與前提條件
- 分析目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
第3章：市場動態、監管與趨勢分析
- 市場動態
- 影響分析
- 監管趨勢
- 產品上市及核准
- PEST分析
- 波特的分析
- 併購情景
第4章 全球慢性疼痛市場：依藥物類別分類，2021-2033年
- 鴉片類藥物
- 非類固醇消炎劑（NSAIDs）
- 抗驚厥藥物
- 抗憂鬱症
- 其他
第5章 全球慢性疼痛市場：依適應症分類，2021-2033年
- 神經病變疼痛
- 關節疼痛
- 慢性腰痛
- 癌症疼痛
- 偏頭痛
- 纖維肌痛
- 其他
第6章 全球慢性疼痛市場：依應用領域分類，2021-2033年
- 肌肉骨骼系統
- 神經病變
- 腫瘤學
- 其他
第7章 全球慢性疼痛市場：依通路分類，2021-2033年
- 醫院藥房
- 零售藥房
- 網路藥房
第8章 全球慢性疼痛市場：依地區分類，2021-2033年
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
- 歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
- 中東
- GCC
- 以色列
- 其他中東國家
- 非洲
- 南非
- 北非
- 中非
第9章 競爭情勢
- Pfizer Inc.
- Johnson & Johnson
- GlaxoSmithKline PLC
- Bayer AG
- Novartis AG
- Endo Pharmaceuticals
- Bristol-Myers Squibb
- Eli Lilly and Company
- Teva Pharmaceutical Industries Ltd.
- Reckitt Benckiser Group plc
- Medtronic plc
- AstraZeneca PLC
- Becton, Dickinson and Company
- AbbVie Inc.
- Horizon Therapeutics
- Mallinckrodt Pharmaceuticals
- Zynerba Pharmaceuticals
- Neurocrine Biosciences
- Sorrento Therapeutics
- Cypress Pharmaceutical
第10章 分析師建議
- 機會分析
- 一致的機會地圖
第11章 參考文獻與調查方法
- 參考
- 調查方法
- 關於本公司
簡介目錄
Product Code: CMI4767
Chronic Pain Market is estimated to be valued at USD 83.02 Bn in 2026 and is expected to reach USD 136.84 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 83.02 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.40% | 2033 Value Projection: | USD 136.84 Bn |
Chronic pain is defined as any pain lasting for more than three months or past the normal time of healing. The conditions that cause chronic pain are numerous and wide-ranging from arthritis, back pain, cancer, neurological disorders and fibromyalgia among others. Sedentary lifestyles and rising chronic diseases can increase the prevalence of chronic pain globally. It negatively impacts quality of life by limiting mobility and daily functioning. Global chronic pain market consists of drugs for pain management, neuromodulation devices, and other treatment modalities that provide relief and improve patient outcomes. Rapid growth in geriatric population who are more prone to such conditions, rise in healthcare expenditure, new product launches, and increasing awareness about management options can drive the market growth.
Market Dynamics
Increasing prevalence of chronic diseases and injuries has significantly contributed to rising incidence of chronic pain worldwide. These include musculoskeletal disorders like osteoarthritis and lower back pain. Growing geriatric population who are more susceptible to such conditions can drive the market growth. Furthermore, greater healthcare spending, new product innovations, and ability to pay for expensive treatment options can also drive the market growth. However, presence of alternatives like generic drugs, non-compliance to medications, and side effects of certain therapies can pose challenges to market players. Moreover, regulatory hurdles for new product approvals can also hamper the market growth. Emerging economies provide major opportunities for industry players. Technological advancements in pain treatment modalities can open new avenues for the market growth.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global chronic pain market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Pfizer, Eli Lilly, GlaxoSmithKline, Novartis, Johnson & Johnson, AstraZeneca, Purdue Pharma, Endo Pharmaceuticals, Teva Pharmaceuticals Industries Ltd., and Mallinckrodt Pharmaceuticals.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global chronic pain market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global chronic pain market.
Market Segmentation
- By Drug Class Insights (Revenue, USD Bn, 2021 - 2033)
- Opioids
- Non-steroidal anti-inflammatory drugs (NSAIDS)
- Anticonvulsants
- Antidepressants
- Others
- By Indication Insights (Revenue, USD Bn, 2021 - 2033)
- Neuropathic pain
- Arthritis pain
- Chronic back pain
- Cancer pain
- Migraine
- Fibromyalgia
- Others
- By Application Insights (Revenue, USD Bn, 2021 - 2033)
- Musculoskeletal
- Neuropathy
- Oncology
- Others
- By Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Pfizer Inc.
- Johnson & Johnson
- GlaxoSmithKline PLC
- Bayer AG
- Novartis AG
- Endo Pharmaceuticals
- Bristol-Myers Squibb
- Eli Lilly and Company
- Teva Pharmaceutical Industries Ltd.
- Reckitt Benckiser Group plc
- Medtronic plc
- AstraZeneca PLC
- Becton, Dickinson and Company
- AbbVie Inc.
- Horizon Therapeutics
- Mallinckrodt Pharmaceuticals
- Zynerba Pharmaceuticals
- Neurocrine Biosciences
- Sorrento Therapeutics
- Cypress Pharmaceutical
Table of Contents
1. RESEARCH OBJECTIVES AND ASSUMPTIONS
- Research Objectives
- Assumptions
- Abbreviations
2. MARKET PURVIEW
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Chronic Pain Market, By Drug Class
- Global Chronic Pain Market, By Indication
- Global Chronic Pain Market, By Application
- Global Chronic Pain Market, By Distribution Channel
- Global Chronic Pain Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Chronic Pain Market, By Drug Class, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Opioids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Non-steroidal anti-inflammatory drugs (NSAIDS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Anticonvulsants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Antidepressants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Chronic Pain Market, By Indication, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Neuropathic pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Arthritis pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Chronic back pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cancer pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Migraine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Fibromyalgia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Chronic Pain Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Musculoskeletal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Neuropathy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Chronic Pain Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Chronic Pain Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026,2028 & 2033, (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2033, (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, (USD Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GlaxoSmithKline PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Endo Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bristol-Myers Squibb
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Reckitt Benckiser Group plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AstraZeneca PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Horizon Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mallinckrodt Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Zynerba Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Neurocrine Biosciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sorrento Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cypress Pharmaceutical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
02-2729-4219
+886-2-2729-4219
脊髓幫浦市場－全球產業規模、佔有率、趨勢、機會、預測：按應用、最終用戶、地區和競爭格局分類，2021-2031年
脊髓幫浦市場：2026-2032年全球市場預測（依產品類型、適應症、技術、最終用戶及通路分類）截肢後慢性疼痛管理市場：依治療方法、藥物類別、最終用戶、給藥途徑和疼痛類型分類－2026-2032年全球市場預測
紅斑肢痛症市場分析及預測（至2035年）：依類型、產品類型、服務、技術、應用、最終使用者、部署類型及解決方案分類
全球慢性骨盆疼痛治療市場規模、佔有率、趨勢和成長分析報告（2026-2034年）
止痛藥市場：化挑戰為機會－掌握自我照護止痛市場的機會
脊髓幫浦市場規模、佔有率、趨勢分析報告：按產品、按應用、按最終用途、按地區、細分市場預測，2024-2030 年